|
Market Closed -
Australian S.E.
13:10:10 28/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.0240 AUD | +9.09% |
|
+4.35% | -94.22% |
| 10-23 | Immutep Limited Announces Health-Related Quality of Life Data from Eftisarc-Neo Phase Ii Trial | CI |
| 10-14 | Immutep outlines clinical development priorities and plans for 2027 | FI |
| Market Cap | 35.37M 24.9M 22.34M 20.65M 18.71M 34.95M 2.37B 247M 98.36M 1.24B 93.44M 91.46M 3.94B | P/E 2027 * |
-1.41x | P/E 2028 * | -2.18x |
|---|---|---|---|---|---|
| Enterprise Value | -19.23M -13.54M -12.15M -11.23M -10.17M -19M -1.29B -134M -53.48M -675M -50.8M -49.73M -2.14B | EV / Sales 2027 * |
-4.81x | EV / Sales 2028 * | 0.51x |
| Free-Float |
96.87% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| IMM | Delayed | |
OTC Markets
| PRRUF | Delayed | |
|
Deutsche Boerse AG
| YP1B | Delayed | |
|
Tradegate
| YP1B | Real-time | |
|
Börse Stuttgart
| YP1B | Delayed | |
|
Boerse Muenchen
| YP1B | Real-time |
| 1 day | +9.09% | ||
| 1 week | +4.35% | ||
| Current month | -29.41% | ||
| 1 month | -33.33% | ||
| 3 months | -50.00% | ||
| 6 months | -66.20% | ||
| Current year | -94.22% |
| 1 week | 0.02 |  | 0.02 |
| 1 month | 0.02 | | 0.04 |
| Current year | 0.02 | | 0.47 |
| 1 year | 0.02 | | 0.47 |
| 3 years | 0.02 | | 0.48 |
| 5 years | 0.02 | | 0.71 |
| 10 years | 0.02 | | 0.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Voigt
CEO | Chief Executive Officer | 53 | 09/07/2014 |
David Fang
DFI | Director of Finance/CFO | - | 01/03/2018 |
Stephan Winckels
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Marc Voigt
BRD | Director/Board Member | 53 | 09/07/2014 |
Russell Howard
CHM | Chairman | 76 | 17/11/2017 |
Frédéric Triebel
BRD | Director/Board Member | 71 | 13/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/10/26 | Exercice | Director | -388,889 | 0.0264% | ||
| 1/10/26 | Exercice | Director | 388,889 | 0.0264% | ||
| 18/3/26 | Other | Chief Technology Officer | 14,224,374 | 0.9652% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.09% | +4.35% | -91.86% | -92.38% | 22.8M | |
| +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | |
| +1.76% | +2.10% | +12.10% | +81.21% | 54.55B | |
| -0.94% | +0.77% | +8.85% | +100.19% | 53.59B | |
| +2.76% | +4.18% | +28.34% | +55.07% | 44.75B | |
| +2.00% | -2.90% | +18.37% | +119.04% | 41.62B | |
| +1.34% | -3.98% | +225.44% | +914.08% | 39.91B | |
| +0.64% | -3.85% | +11.71% | +45.57% | 32.47B | |
| +29.06% | +48.65% | +106.84% | +92.73% | 26.7B | |
| +3.72% | -7.45% | +24.25% | -2.99% | 23.36B | |
| Average | +4.99% | -0.81% | +37.76% | +137.30% | 38.05B | |
| Weighted average by Cap. | +3.21% | -0.29% | +47.55% | +161.45% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4M 2.82M 2.53M 2.34M 2.12M 3.95M 268M 27.93M 11.12M 140M 10.57M 10.34M 446M | 3M 2.11M 1.89M 1.75M 1.59M 2.96M 201M 20.95M 8.34M 105M 7.93M 7.76M 334M |
| Net income | -30.92M -21.76M -19.53M -18.05M -16.35M -30.55M -2.07B -216M -85.98M -1.08B -81.67M -79.95M -3.44B | -28M -19.71M -17.68M -16.35M -14.81M -27.66M -1.88B -195M -77.85M -982M -73.96M -72.4M -3.12B |
| Net Debt | -54.6M -38.44M -34.49M -31.88M -28.88M -53.95M -3.66B -381M -152M -1.92B -144M -141M -6.08B | -33.83M -23.82M -21.37M -19.76M -17.89M -33.43M -2.27B -236M -94.09M -1.19B -89.38M -87.49M -3.77B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | A$0.0240 | +9.09% | 4,766,810 |
| 27/10/26 | A$0.0220 | -4.35% | 7,379,385 |
| 26/10/26 | A$0.0230 | 0.00% | 833,486 |
| 23/10/26 | A$0.0230 | +4.55% | 554,119 |
| 22/10/26 | A$0.0220 | -8.33% | 6,219,324 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMM Stock
Select your edition
All financial news and data tailored to specific country editions
